Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Emovit
2. Ici-58,834
3. Ici58,834
4. Viloxazine
5. Viloxazine Hydrochloride, (r)-isomer
6. Viloxazine Hydrochloride, (s)-isomer
7. Viloxazine Oxalate (1:1)
8. Viloxazine, (+-)-isomer
9. Viloxazine, (r)-isomer
10. Viloxazine, (s)-isomer
11. Vivalan
1. 35604-67-2
2. 2-((2-ethoxyphenoxy)methyl)morpholine Hydrochloride
3. Viloxazine Hcl
4. Vivalan
5. Emovit
6. Vicilan
7. 2-[(2-ethoxyphenoxy)methyl]morpholine Hydrochloride
8. Rac Viloxazine Hydrochloride
9. Viloxacina Clorhidrato
10. Ici 58,834
11. Viloxazine Hydrochloride [usan]
12. 2-((2-ethoxyphenoxy)methyl)morpholinehydrochloride
13. 2-[(2-ethoxyphenoxy)methyl]morpholine;hydrochloride
14. 2-((o-ethoxyphenoxy)methyl)morpholine Hydrochloride
15. Spn-812
16. Oqw30i1332
17. Qelbree
18. 2-[(2-ethoxy Phenoxy)methyl]morpholine Hydrochloride
19. Morpholine, 2-((2-ethoxyphenoxy)methyl)-, Hydrochloride
20. Morpholine, 2-[(2-ethoxyphenoxy)methyl]-, Hydrochloride
21. Ici-58834
22. Viloxazine Hydrochloride (usan)
23. Ccris 1915
24. Viloxacina Clorhidrato [spanish]
25. Einecs 252-638-6
26. Unii-oqw30i1332
27. Prestwick_734
28. Vivalan (tn)
29. Cloridrato De Viloxazina
30. 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine Hydrochloride
31. Chlorhydrate De Viloxazine
32. 2-(2-ethoxyphenoxymethyl)-2,3,5,6-tetrahydro-1,4-oxazine Hydrochloride
33. Dsstox_cid_31511
34. Dsstox_rid_97396
35. Dsstox_gsid_57722
36. Schembl300741
37. Chembl2106483
38. Dtxsid8057722
39. Glxc-25714
40. Tox21_113955
41. Viloxazine Hydrochloride [mi]
42. Akos015847050
43. At27980
44. Ccg-220828
45. Viloxazine Hydrochloride [mart.]
46. Ncgc00262964-01
47. Viloxazine Hydrochloride [who-dd]
48. Cas-35604-67-2
49. A6217
50. Ft-0675815
51. Ft-0675816
52. Ft-0675817
53. Ft-0675818
54. Ft-0675819
55. Viloxazine Hydrochloride [orange Book]
56. D02572
57. 2-(o-ethoxyphenoxymethyl)morpholine Hydrochloride
58. 604e672
59. Sr-01000872636
60. Sr-01000872636-1
61. W-110863
62. 2-(2-ethoxy-phenoxymethyl)-morpholine; Hydrochloride
63. 2-[(2-ethoxyphenoxy)-methyl]morpholine Hydrochloride
64. Q27285797
65. 2-(2-ethoxy-phenoxymethyl)-tetra-hydro-1,4-oxazine Hydrochloride
66. (+/-)-morpholine, 2-((2-ethoxyphenoxy)methyl)-, Hydrochloride
Molecular Weight | 273.75 g/mol |
---|---|
Molecular Formula | C13H20ClNO3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 273.1131712 g/mol |
Monoisotopic Mass | 273.1131712 g/mol |
Topological Polar Surface Area | 39.7 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 213 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
Adrenergic Uptake Inhibitors
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39333
Submission : 2023-12-30
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Macsen Labs, a leader in Chemistry since 1952, specializing in APIs, specialty and fine chemicals, and dyes.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39582
Submission : 2024-03-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40737
Submission : 2024-12-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39715
Submission : 2024-06-04
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-12-17
Pay. Date : 2024-10-21
DMF Number : 40648
Submission : 2024-11-07
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-12-13
Pay. Date : 2024-10-31
DMF Number : 40485
Submission : 2024-09-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37860
Submission : 2022-12-27
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39333
Submission : 2023-12-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40004
Submission : 2024-05-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39799
Submission : 2024-05-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-12-17
Pay. Date : 2024-10-21
DMF Number : 40648
Submission : 2024-11-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-05-21
Pay. Date : 2024-05-10
DMF Number : 39826
Submission : 2024-04-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39582
Submission : 2024-03-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-12-13
Pay. Date : 2024-10-31
DMF Number : 40485
Submission : 2024-09-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37560
Submission : 2022-09-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-12-17
Pay. Date : 2024-11-22
DMF Number : 38637
Submission : 2023-08-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39715
Submission : 2024-06-04
Status : Active
Type : II
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 51504-0023
Start Marketing Date : 2020-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58032-3002
Start Marketing Date : 2023-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17373-1021
Start Marketing Date : 2024-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84386-014
Start Marketing Date : 2024-10-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65089-0064
Start Marketing Date : 2023-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71666-015
Start Marketing Date : 2023-08-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-039
Start Marketing Date : 2022-09-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71666-016
Start Marketing Date : 2023-09-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...
Macsen Labs, a leader in Chemistry since 1952, specializing in APIs, specialty and fine chemicals, and dyes.
About the Company : Macsen is a USFDA registered, TGA GMP & WHO-GMP certified manufacturer and supplier of Active Pharmaceutical Ingredients (APIs), Biological Stains & Specialty Fine Chemicals. Our c...
About the Company : Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutica...
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
About the Company : Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its ex...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Viloxazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Viloxazine, including repackagers and relabelers. The FDA regulates Viloxazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Viloxazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Viloxazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Viloxazine supplier is an individual or a company that provides Viloxazine active pharmaceutical ingredient (API) or Viloxazine finished formulations upon request. The Viloxazine suppliers may include Viloxazine API manufacturers, exporters, distributors and traders.
click here to find a list of Viloxazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Viloxazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Viloxazine active pharmaceutical ingredient (API) in detail. Different forms of Viloxazine DMFs exist exist since differing nations have different regulations, such as Viloxazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Viloxazine DMF submitted to regulatory agencies in the US is known as a USDMF. Viloxazine USDMF includes data on Viloxazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Viloxazine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Viloxazine suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Viloxazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Viloxazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Viloxazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Viloxazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Viloxazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Viloxazine suppliers with NDC on PharmaCompass.
Viloxazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Viloxazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Viloxazine GMP manufacturer or Viloxazine GMP API supplier for your needs.
A Viloxazine CoA (Certificate of Analysis) is a formal document that attests to Viloxazine's compliance with Viloxazine specifications and serves as a tool for batch-level quality control.
Viloxazine CoA mostly includes findings from lab analyses of a specific batch. For each Viloxazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Viloxazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Viloxazine EP), Viloxazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Viloxazine USP).
LOOKING FOR A SUPPLIER?